[HTML][HTML] A platform for generation of chamber-specific cardiac tissues and disease modeling
Tissue engineering using cardiomyocytes derived from human pluripotent stem cells holds a
promise to revolutionize drug discovery, but only if limitations related to cardiac chamber …
promise to revolutionize drug discovery, but only if limitations related to cardiac chamber …
[HTML][HTML] A Platform for Generation of Chamber-Specific Cardiac Tissues and Disease Modeling
Y Zhao, N Rafatian, NT Feric, BJ Cox, R Aschar-Sobbi… - Cell, 2019 - Elsevier
Tissue engineering using cardiomyocytes derived from human pluripotent stem cells holds a
promise to revolutionize drug discovery, but only if limitations related to cardiac chamber …
promise to revolutionize drug discovery, but only if limitations related to cardiac chamber …
[HTML][HTML] A platform for generation of chamber specific cardiac tissues and disease modelling
Y Zhao, N Rafatian, NT Feric, B Cox, R Aschar-Sobbi… - Cell, 2019 - ncbi.nlm.nih.gov
Tissue engineering using cardiomyocytes derived from human pluripotent stem cells holds a
promise to revolutionise drug discovery, but only if limitations related to cardiac chamber …
promise to revolutionise drug discovery, but only if limitations related to cardiac chamber …
[HTML][HTML] A Platform for Generation of Chamber-Specific Cardiac Tissues and Disease Modeling
Y Zhao, N Rafatian, NT Feric, BJ Cox, R Aschar-Sobbi… - Cell, 2019 - cell.com
Tissue engineering using cardiomyocytes derived from human pluripotent stem cells holds a
promise to revolutionize drug discovery, but only if limitations related to cardiac chamber …
promise to revolutionize drug discovery, but only if limitations related to cardiac chamber …
A Platform for Generation of Chamber-Specific Cardiac Tissues and Disease Modeling
Y Zhao, N Rafatian, NT Feric, BJ Cox… - Cell, 2019 - pubmed.ncbi.nlm.nih.gov
Tissue engineering using cardiomyocytes derived from human pluripotent stem cells holds a
promise to revolutionize drug discovery, but only if limitations related to cardiac chamber …
promise to revolutionize drug discovery, but only if limitations related to cardiac chamber …
A Platform for Generation of Chamber-Specific Cardiac Tissues and Disease Modeling.
Y Zhao, N Rafatian, NT Feric, BJ Cox, R Aschar-Sobbi… - Cell, 2019 - europepmc.org
Tissue engineering using cardiomyocytes derived from human pluripotent stem cells holds a
promise to revolutionise drug discovery, but only if limitations related to cardiac chamber …
promise to revolutionise drug discovery, but only if limitations related to cardiac chamber …
[PDF][PDF] A Platform for Generation of Chamber-Specific Cardiac Tissues and Disease Modeling
Y Zhao, N Rafatian, NT Feric, BJ Cox, R Aschar-Sobbi… - Cell, 2019 - academia.edu
Tissue engineering using cardiomyocytes derived from human pluripotent stem cells holds a
promise to revolutionize drug discovery, but only if limitations related to cardiac chamber …
promise to revolutionize drug discovery, but only if limitations related to cardiac chamber …
[引用][C] A Platform for Generation of Chamber-Specific Cardiac Tissues and Disease Modeling
Y Zhao, N Rafatian, NT Feric, BJ Cox, R Aschar-Sobbi… - Cell, 2019 - cir.nii.ac.jp